Gene Therapy Products Market - Global Outlook and Forecast 2024-2031

Report ID: 611608 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Gene Therapy Products Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gene Therapy Products Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Products Overall Market Size
    2.1 Global Gene Therapy Products Market Size: 2021 VS 2027
    2.2 Global Gene Therapy Products Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Gene Therapy Products Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Gene Therapy Products Players in Global Market
    3.2 Top Global Gene Therapy Products Companies Ranked by Revenue
    3.3 Global Gene Therapy Products Revenue by Companies
    3.4 Global Gene Therapy Products Sales by Companies
    3.5 Global Gene Therapy Products Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Gene Therapy Products Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Gene Therapy Products Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Gene Therapy Products Players in Global Market
        3.8.1 List of Global Tier 1 Gene Therapy Products Companies
        3.8.2 List of Global Tier 2 and Tier 3 Gene Therapy Products Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Gene Therapy Products Market Size Markets, 2021 & 2027
        4.1.2 Ex vivo
        4.1.3 In Vivo
    4.2 By Type - Global Gene Therapy Products Revenue & Forecasts
        4.2.1 By Type - Global Gene Therapy Products Revenue, 2016-2021
        4.2.2 By Type - Global Gene Therapy Products Revenue, 2022-2027
        4.2.3 By Type - Global Gene Therapy Products Revenue Market Share, 2016-2027
    4.3 By Type - Global Gene Therapy Products Sales & Forecasts
        4.3.1 By Type - Global Gene Therapy Products Sales, 2016-2021
        4.3.2 By Type - Global Gene Therapy Products Sales, 2022-2027
        4.3.3 By Type - Global Gene Therapy Products Sales Market Share, 2016-2027
    4.4 By Type - Global Gene Therapy Products Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gene Therapy Products Market Size, 2021 & 2027
        5.1.2 Cancer
        5.1.3 Monogenic
        5.1.4 Infectious disease
        5.1.5 Cardiovascular disease
        5.1.6 Other
    5.2 By Application - Global Gene Therapy Products Revenue & Forecasts
        5.2.1 By Application - Global Gene Therapy Products Revenue, 2016-2021
        5.2.2 By Application - Global Gene Therapy Products Revenue, 2022-2027
        5.2.3 By Application - Global Gene Therapy Products Revenue Market Share, 2016-2027
    5.3 By Application - Global Gene Therapy Products Sales & Forecasts
        5.3.1 By Application - Global Gene Therapy Products Sales, 2016-2021
        5.3.2 By Application - Global Gene Therapy Products Sales, 2022-2027
        5.3.3 By Application - Global Gene Therapy Products Sales Market Share, 2016-2027
    5.4 By Application - Global Gene Therapy Products Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Gene Therapy Products Market Size, 2021 & 2027
    6.2 By Region - Global Gene Therapy Products Revenue & Forecasts
        6.2.1 By Region - Global Gene Therapy Products Revenue, 2016-2021
        6.2.2 By Region - Global Gene Therapy Products Revenue, 2022-2027
        6.2.3 By Region - Global Gene Therapy Products Revenue Market Share, 2016-2027
    6.3 By Region - Global Gene Therapy Products Sales & Forecasts
        6.3.1 By Region - Global Gene Therapy Products Sales, 2016-2021
        6.3.2 By Region - Global Gene Therapy Products Sales, 2022-2027
        6.3.3 By Region - Global Gene Therapy Products Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Gene Therapy Products Revenue, 2016-2027
        6.4.2 By Country - North America Gene Therapy Products Sales, 2016-2027
        6.4.3 US Gene Therapy Products Market Size, 2016-2027
        6.4.4 Canada Gene Therapy Products Market Size, 2016-2027
        6.4.5 Mexico Gene Therapy Products Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Gene Therapy Products Revenue, 2016-2027
        6.5.2 By Country - Europe Gene Therapy Products Sales, 2016-2027
        6.5.3 Germany Gene Therapy Products Market Size, 2016-2027
        6.5.4 France Gene Therapy Products Market Size, 2016-2027
        6.5.5 U.K. Gene Therapy Products Market Size, 2016-2027
        6.5.6 Italy Gene Therapy Products Market Size, 2016-2027
        6.5.7 Russia Gene Therapy Products Market Size, 2016-2027
        6.5.8 Nordic Countries Gene Therapy Products Market Size, 2016-2027
        6.5.9 Benelux Gene Therapy Products Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Gene Therapy Products Revenue, 2016-2027
        6.6.2 By Region - Asia Gene Therapy Products Sales, 2016-2027
        6.6.3 China Gene Therapy Products Market Size, 2016-2027
        6.6.4 Japan Gene Therapy Products Market Size, 2016-2027
        6.6.5 South Korea Gene Therapy Products Market Size, 2016-2027
        6.6.6 Southeast Asia Gene Therapy Products Market Size, 2016-2027
        6.6.7 India Gene Therapy Products Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Gene Therapy Products Revenue, 2016-2027
        6.7.2 By Country - South America Gene Therapy Products Sales, 2016-2027
        6.7.3 Brazil Gene Therapy Products Market Size, 2016-2027
        6.7.4 Argentina Gene Therapy Products Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Gene Therapy Products Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Gene Therapy Products Sales, 2016-2027
        6.8.3 Turkey Gene Therapy Products Market Size, 2016-2027
        6.8.4 Israel Gene Therapy Products Market Size, 2016-2027
        6.8.5 Saudi Arabia Gene Therapy Products Market Size, 2016-2027
        6.8.6 UAE Gene Therapy Products Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Bluebird Bio
        7.1.1 Bluebird Bio Corporate Summary
        7.1.2 Bluebird Bio Business Overview
        7.1.3 Bluebird Bio Gene Therapy Products Major Product Offerings
        7.1.4 Bluebird Bio Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.1.5 Bluebird Bio Key News
    7.2 Sangamo
        7.2.1 Sangamo Corporate Summary
        7.2.2 Sangamo Business Overview
        7.2.3 Sangamo Gene Therapy Products Major Product Offerings
        7.2.4 Sangamo Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.2.5 Sangamo Key News
    7.3 Spark Therapeutics
        7.3.1 Spark Therapeutics Corporate Summary
        7.3.2 Spark Therapeutics Business Overview
        7.3.3 Spark Therapeutics Gene Therapy Products Major Product Offerings
        7.3.4 Spark Therapeutics Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.3.5 Spark Therapeutics Key News
    7.4 Dimension Therapeutics
        7.4.1 Dimension Therapeutics Corporate Summary
        7.4.2 Dimension Therapeutics Business Overview
        7.4.3 Dimension Therapeutics Gene Therapy Products Major Product Offerings
        7.4.4 Dimension Therapeutics Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.4.5 Dimension Therapeutics Key News
    7.5 Avalanche Bio
        7.5.1 Avalanche Bio Corporate Summary
        7.5.2 Avalanche Bio Business Overview
        7.5.3 Avalanche Bio Gene Therapy Products Major Product Offerings
        7.5.4 Avalanche Bio Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.5.5 Avalanche Bio Key News
    7.6 Celladon
        7.6.1 Celladon Corporate Summary
        7.6.2 Celladon Business Overview
        7.6.3 Celladon Gene Therapy Products Major Product Offerings
        7.6.4 Celladon Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.6.5 Celladon Key News
    7.7 Vical Inc.
        7.7.1 Vical Inc. Corporate Summary
        7.7.2 Vical Inc. Business Overview
        7.7.3 Vical Inc. Gene Therapy Products Major Product Offerings
        7.4.4 Vical Inc. Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.7.5 Vical Inc. Key News
    7.8 Advantagene
        7.8.1 Advantagene Corporate Summary
        7.8.2 Advantagene Business Overview
        7.8.3 Advantagene Gene Therapy Products Major Product Offerings
        7.8.4 Advantagene Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.8.5 Advantagene Key News
8 Global Gene Therapy Products Production Capacity, Analysis
    8.1 Global Gene Therapy Products Production Capacity, 2016-2027
    8.2 Gene Therapy Products Production Capacity of Key Manufacturers in Global Market
    8.3 Global Gene Therapy Products Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Gene Therapy Products Supply Chain Analysis
    10.1 Gene Therapy Products Industry Value Chain
    10.2 Gene Therapy Products Upstream Market
    10.3 Gene Therapy Products Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Gene Therapy Products Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
1 Introduction to Research & Analysis Reports
    1.1 Gene Therapy Products Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gene Therapy Products Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy Products Overall Market Size
    2.1 Global Gene Therapy Products Market Size: 2021 VS 2027
    2.2 Global Gene Therapy Products Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Gene Therapy Products Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Gene Therapy Products Players in Global Market
    3.2 Top Global Gene Therapy Products Companies Ranked by Revenue
    3.3 Global Gene Therapy Products Revenue by Companies
    3.4 Global Gene Therapy Products Sales by Companies
    3.5 Global Gene Therapy Products Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Gene Therapy Products Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Gene Therapy Products Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Gene Therapy Products Players in Global Market
        3.8.1 List of Global Tier 1 Gene Therapy Products Companies
        3.8.2 List of Global Tier 2 and Tier 3 Gene Therapy Products Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Gene Therapy Products Market Size Markets, 2021 & 2027
        4.1.2 Ex vivo
        4.1.3 In Vivo
    4.2 By Type - Global Gene Therapy Products Revenue & Forecasts
        4.2.1 By Type - Global Gene Therapy Products Revenue, 2016-2021
        4.2.2 By Type - Global Gene Therapy Products Revenue, 2022-2027
        4.2.3 By Type - Global Gene Therapy Products Revenue Market Share, 2016-2027
    4.3 By Type - Global Gene Therapy Products Sales & Forecasts
        4.3.1 By Type - Global Gene Therapy Products Sales, 2016-2021
        4.3.2 By Type - Global Gene Therapy Products Sales, 2022-2027
        4.3.3 By Type - Global Gene Therapy Products Sales Market Share, 2016-2027
    4.4 By Type - Global Gene Therapy Products Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gene Therapy Products Market Size, 2021 & 2027
        5.1.2 Cancer
        5.1.3 Monogenic
        5.1.4 Infectious disease
        5.1.5 Cardiovascular disease
        5.1.6 Other
    5.2 By Application - Global Gene Therapy Products Revenue & Forecasts
        5.2.1 By Application - Global Gene Therapy Products Revenue, 2016-2021
        5.2.2 By Application - Global Gene Therapy Products Revenue, 2022-2027
        5.2.3 By Application - Global Gene Therapy Products Revenue Market Share, 2016-2027
    5.3 By Application - Global Gene Therapy Products Sales & Forecasts
        5.3.1 By Application - Global Gene Therapy Products Sales, 2016-2021
        5.3.2 By Application - Global Gene Therapy Products Sales, 2022-2027
        5.3.3 By Application - Global Gene Therapy Products Sales Market Share, 2016-2027
    5.4 By Application - Global Gene Therapy Products Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Gene Therapy Products Market Size, 2021 & 2027
    6.2 By Region - Global Gene Therapy Products Revenue & Forecasts
        6.2.1 By Region - Global Gene Therapy Products Revenue, 2016-2021
        6.2.2 By Region - Global Gene Therapy Products Revenue, 2022-2027
        6.2.3 By Region - Global Gene Therapy Products Revenue Market Share, 2016-2027
    6.3 By Region - Global Gene Therapy Products Sales & Forecasts
        6.3.1 By Region - Global Gene Therapy Products Sales, 2016-2021
        6.3.2 By Region - Global Gene Therapy Products Sales, 2022-2027
        6.3.3 By Region - Global Gene Therapy Products Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Gene Therapy Products Revenue, 2016-2027
        6.4.2 By Country - North America Gene Therapy Products Sales, 2016-2027
        6.4.3 US Gene Therapy Products Market Size, 2016-2027
        6.4.4 Canada Gene Therapy Products Market Size, 2016-2027
        6.4.5 Mexico Gene Therapy Products Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Gene Therapy Products Revenue, 2016-2027
        6.5.2 By Country - Europe Gene Therapy Products Sales, 2016-2027
        6.5.3 Germany Gene Therapy Products Market Size, 2016-2027
        6.5.4 France Gene Therapy Products Market Size, 2016-2027
        6.5.5 U.K. Gene Therapy Products Market Size, 2016-2027
        6.5.6 Italy Gene Therapy Products Market Size, 2016-2027
        6.5.7 Russia Gene Therapy Products Market Size, 2016-2027
        6.5.8 Nordic Countries Gene Therapy Products Market Size, 2016-2027
        6.5.9 Benelux Gene Therapy Products Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Gene Therapy Products Revenue, 2016-2027
        6.6.2 By Region - Asia Gene Therapy Products Sales, 2016-2027
        6.6.3 China Gene Therapy Products Market Size, 2016-2027
        6.6.4 Japan Gene Therapy Products Market Size, 2016-2027
        6.6.5 South Korea Gene Therapy Products Market Size, 2016-2027
        6.6.6 Southeast Asia Gene Therapy Products Market Size, 2016-2027
        6.6.7 India Gene Therapy Products Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Gene Therapy Products Revenue, 2016-2027
        6.7.2 By Country - South America Gene Therapy Products Sales, 2016-2027
        6.7.3 Brazil Gene Therapy Products Market Size, 2016-2027
        6.7.4 Argentina Gene Therapy Products Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Gene Therapy Products Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Gene Therapy Products Sales, 2016-2027
        6.8.3 Turkey Gene Therapy Products Market Size, 2016-2027
        6.8.4 Israel Gene Therapy Products Market Size, 2016-2027
        6.8.5 Saudi Arabia Gene Therapy Products Market Size, 2016-2027
        6.8.6 UAE Gene Therapy Products Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Bluebird Bio
        7.1.1 Bluebird Bio Corporate Summary
        7.1.2 Bluebird Bio Business Overview
        7.1.3 Bluebird Bio Gene Therapy Products Major Product Offerings
        7.1.4 Bluebird Bio Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.1.5 Bluebird Bio Key News
    7.2 Sangamo
        7.2.1 Sangamo Corporate Summary
        7.2.2 Sangamo Business Overview
        7.2.3 Sangamo Gene Therapy Products Major Product Offerings
        7.2.4 Sangamo Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.2.5 Sangamo Key News
    7.3 Spark Therapeutics
        7.3.1 Spark Therapeutics Corporate Summary
        7.3.2 Spark Therapeutics Business Overview
        7.3.3 Spark Therapeutics Gene Therapy Products Major Product Offerings
        7.3.4 Spark Therapeutics Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.3.5 Spark Therapeutics Key News
    7.4 Dimension Therapeutics
        7.4.1 Dimension Therapeutics Corporate Summary
        7.4.2 Dimension Therapeutics Business Overview
        7.4.3 Dimension Therapeutics Gene Therapy Products Major Product Offerings
        7.4.4 Dimension Therapeutics Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.4.5 Dimension Therapeutics Key News
    7.5 Avalanche Bio
        7.5.1 Avalanche Bio Corporate Summary
        7.5.2 Avalanche Bio Business Overview
        7.5.3 Avalanche Bio Gene Therapy Products Major Product Offerings
        7.5.4 Avalanche Bio Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.5.5 Avalanche Bio Key News
    7.6 Celladon
        7.6.1 Celladon Corporate Summary
        7.6.2 Celladon Business Overview
        7.6.3 Celladon Gene Therapy Products Major Product Offerings
        7.6.4 Celladon Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.6.5 Celladon Key News
    7.7 Vical Inc.
        7.7.1 Vical Inc. Corporate Summary
        7.7.2 Vical Inc. Business Overview
        7.7.3 Vical Inc. Gene Therapy Products Major Product Offerings
        7.4.4 Vical Inc. Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.7.5 Vical Inc. Key News
    7.8 Advantagene
        7.8.1 Advantagene Corporate Summary
        7.8.2 Advantagene Business Overview
        7.8.3 Advantagene Gene Therapy Products Major Product Offerings
        7.8.4 Advantagene Gene Therapy Products Sales and Revenue in Global (2016-2021)
        7.8.5 Advantagene Key News
8 Global Gene Therapy Products Production Capacity, Analysis
    8.1 Global Gene Therapy Products Production Capacity, 2016-2027
    8.2 Gene Therapy Products Production Capacity of Key Manufacturers in Global Market
    8.3 Global Gene Therapy Products Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Gene Therapy Products Supply Chain Analysis
    10.1 Gene Therapy Products Industry Value Chain
    10.2 Gene Therapy Products Upstream Market
    10.3 Gene Therapy Products Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Gene Therapy Products Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Gene Therapy Products Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapy Products Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapy Products Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports